Kidney Transplant Failure Clinical Trial
Official title:
Computer Based, vs Human Based Assessment of Kidney Allograft Failure Prediction and Stratification
The clinical decision-making after kidney transplantation is mainly driven by patient individual assessment. However, this task remains difficult and uncertain due to the integration of complex and numerous parameters. We aim to evaluate and compare the ability of transplant physicians to predict long term allograft survival compared with a computer-based survival prediction algorithm (iBox system).
400 kidney transplant recipients among the cohort of 4,000 patients from the Paris Transplant Group prospective kidney transplant cohort (NCT03474003) were randomly selected. We generated an anonymized electronic health record for each included patient including a total of 60 classical kidney transplant prognostic parameters comprising baseline transplant and recipient characteristics, together with post-transplant parameters including allograft function, proteinuria, histology, diagnoses, and immunological profile collected during the first-year post-transplant. The time of risk evaluation for the human and the iBox system were at 1-year post transplant and the death censored allograft survival predictions made at 7 years after risk assessment. We enrolled transplant physicians at various stages of their careers (residents, fellows and seniors) to assign death censored graft survival probabilities at 7 years post risk assessment. The physicians were blinded to the actual patient outcome (allograft failure) and the iBox predictions. The physicians-based predictions will then be compared with the iBox system, a validated computer-based kidney survival prediction system. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04560582 -
Immunosuppression Reduction in Failed Allograft Guided by cfDNA
|
||
Withdrawn |
NCT04216303 -
Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus
|
||
Recruiting |
NCT03689075 -
Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisation
|
Phase 4 | |
Recruiting |
NCT05788276 -
Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys?
|
Phase 4 | |
Recruiting |
NCT03870542 -
Multicenter, Prospective Study for Urinary Exosomal Biomarkers of Kidney Allograft Tubulointerstitial Fibrosis
|
||
Active, not recruiting |
NCT04882254 -
Normothermic Machine Perfusion: an Additional Value for Kidney Transplant Outcomes?
|
Phase 2 | |
Active, not recruiting |
NCT04897438 -
Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection
|
N/A | |
Enrolling by invitation |
NCT05285878 -
Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation
|
Phase 2 | |
Recruiting |
NCT04226859 -
Trajectories of Glomerular Filtration Rate and Progression to End Stage Renal Disease After Kidney Transplantation
|
||
Recruiting |
NCT06056518 -
Investigating the Impact of AI on Shared Decision Making in Post-kidney Transplant Care
|
N/A | |
Completed |
NCT05619679 -
A Clinical Practice Snapshot on Pediatric Kidney Transplantation
|
||
Completed |
NCT06020534 -
Aortoiliac Stenosis in Kidney Transplantation
|
||
Active, not recruiting |
NCT02960802 -
Kidney Transplantation and Renal and Myocardial Perfusion
|
N/A | |
Completed |
NCT05200949 -
SURGICAL EXPERIENCE ON RENAL TRANSPLANT COMPLICATIONS
|
||
Completed |
NCT04258891 -
Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation
|
||
Recruiting |
NCT06186843 -
Plant-based Diet for Kidney Transplant Recipients
|
N/A | |
Active, not recruiting |
NCT04154267 -
Protocol Biopsies in High-risk Renal Transplant Recipients
|
N/A |